Ieq Capital »

Abcellera Biologics shares owned by Ieq Capital

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Ieq Capital from 13F filings

Historical chart of Ieq Capital investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Ieq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Ieq Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 246k 5.03

More positions owned by Ieq Capital

Applovin Corp Com Cl A (APP)
Roblox Corp Cl A (RBLX)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Crowdstrike Hldgs Cl A (CRWD)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Snowflake Com Shs (SNOW)

View all positions for Ieq Capital

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Baillie Gifford & Co
Two Sigma Investments
Two Sigma Advisers
Arrowpoint Asset Management
BlackRock
Renaissance Technologies
Tang Capital Management
UBS Group
Millennium Management
Susquehanna International
Guardian Partners
Driehaus Capital Management
Citadel Advisors

View all funds holding Abcellera Biologics